Your browser doesn't support javascript.
loading
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus nab-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic Cancer.
Sahai, Vaibhav; Saif, M Wasif; Kalyan, Aparna; Philip, Philip A; Rocha-Lima, Caio M; Ocean, Allyson; Ondovik, Michael S; Simeone, Diane M; Banerjee, Sibabrata; Bhore, Rafia; Louis, Chrystal U; Picozzi, Vincent.
Afiliação
  • Sahai V; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Saif MW; Medical Oncology, Northwell Health Cancer Institute, Lake Success, New York.
  • Kalyan A; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Philip PA; Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan.
  • Rocha-Lima CM; Department of Oncology, Wake Forest School of Medicine, Bowman Gray Center, Winston-Salem, North Carolina.
  • Ocean A; Department of Medical Oncology, Weill Cornell Medicine, New York, New York.
  • Ondovik MS; Department of Medical Affairs, Celgene Corporation, Summit, New Jersey.
  • Simeone DM; Department of General Surgery, NYU Langone Perlmutter Cancer Center, New York, New York.
  • Banerjee S; Department of Medical Affairs, Celgene Corporation, Summit, New Jersey.
  • Bhore R; Department of Medical Affairs, Celgene Corporation, Summit, New Jersey.
  • Louis CU; Department of Medical Affairs, Celgene Corporation, Summit, New Jersey.
  • Picozzi V; Department of Oncology, Virginia Mason Medical Center, Seattle, Washington.
J Pancreat Cancer ; 5(1): 35-42, 2019.
Article em En | MEDLINE | ID: mdl-31559379

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: J Pancreat Cancer Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: J Pancreat Cancer Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos